End User Segment to Lead DVT Preventive Pump during 2022-2028

According to our latest study on "DVT Preventive Pump Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type and End User," the market is expected to grow from US$ 383.86 million in 2021 to US$ 519.81 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2022 to 2028. The rising cases of cardiac disorders and stroke and the rising prevalence of deep vein thrombosis (DVT) among the geriatric population are boosting the growth of the DVT preventive pump market. However, the lack of skilled professionals, side effects associated with pumps, and availability of alternatives are hampering the market growth.

The incidence of DVT is significantly increased in patients with lower extremity fractures due to risk factors such as staying in bed for a long time, surgery, and trauma. Therefore, DVT screening and prevention during hospitalization have received extensive attention. A retrospective study titled "Deep Vein Thrombosis in the Uninjured Limb in Patients with Lower Extremity Fractures," published in June 2020 included a sample of 494 patients aged 16-94 years that were surgically treated for lower extremity fractures. Further, the ultrasonography data regarding DVT during hospitalization shows that 98 patients (19.84%) had DVT in the uninjured limb, 18.2% with peripheral DVT, 0.2% with central DVT, and 1.4% with mixed DVT. Of the 98 patients with DVT in the uninjured limb, 74 (75.5%) had DVT in both lower limbs, and 24 (24.4%) had DVT in the uninjured limb only. Further, the incidence rate of DVT in the uninjured limb was 19.84% during hospitalization.

Therefore, prevention of DVT in hospitalized patients decreases the risk of DVT, minimizing mortality and morbidity. For the relief of patients prone to DVT, hospitals use the external pneumatic compression device, also known DVT preventive pump, for the treatment of blood clots in an acute hospital setting. Thus, the factors mentioned above are expected to fuel the demand for DVT preventive pumps in hospitals and clinics.

Based on end user, the DVT preventive pump is segmented into hospitals and clinics, surgical centers, and others. The hospitals and clinics segment is likely to hold the largest share of the market in 2022; further, it is expected to register the highest CAGR from 2022 to 2028. The hospital provides healthcare facilities through specialized scientific equipment. The team of trained staff is assigned to deal with the problems associated with modern medical science in hospitals. Various medical research teams are constantly working on introducing innovative therapeutic technologies. Also, growing government funding for hospitals and rising hospitalization of patients support the growth of the DVT preventive pump market in the hospitals & clinics segment.

Impact of COVID-19 Pandemic on DVT Preventive Pump

Patients with comorbidities, particularly diabetes, have a significantly higher risk of venous thromboembolism (VTE) or DVT. The leading VTE risk factor among COVID-19 patients is due to decreased activity. According to a study published in the National Library of Medicine, in 2021, 81 COVID-19 patients in China were reported to develop 25% of VTE in intensive care units. VTE remains a significant cause of increased morbidity and mortality among patients suffering from COVID-19. The high mortality rate among patients having VTE emphasizes the need for further investigation regarding the best preventive, diagnostic, and treatment approaches. Further, the prevalence of DVT is high and is associated with adverse outcomes in hospitalized COVID-19 patients, resulting in patients' morbidity and mortality. Thus, the study demonstrated that COVID-19 patients were more likely to have an incident of VTE, which positively impacted the DVT preventive pump market during the COVID-19 pandemic.

Devon Medical Products Inc, Breg Inc, Bio Compression Systems Inc, Cardinal Health Inc, Arjo AB, Mego Afek Ltd, DJO LLC, Currie Medical Specialties Inc, Zimmer Biomet Holdings Inc, Medcaptain Medical Technology Co Ltd, and ThermoTek Inc are a few of the key companies operating in the DVT preventive pump.

The report segments the DVT preventive pump as follows:

The DVT Preventive Pump market is analyzed based on type, end user, and geography. Based on type, the market is bifurcated into lower extremity and upper extremity. Based on end user, the market is segmented into hospitals and clinics, surgical centers, and others. Geographically, the DVT preventive pump is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of SAM).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com